Clinical Trials Browser

Completed × INDUSTRY × TLC 388 × Clear all

NCT00747474 2019-11-18

Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors

Phase 1 Completed

54 enrolled 30 charts

Other solid neoplasm

Advanced Solid Tumors